Uniting together despite the distance
21 August 2020
Melanoma Institute Australia’s annual Research Retreat was a little different in its 12th year, with COVID-19 keeping us physically apart today. But despite the distance, the unity and sharing of ideas was alive and well with more than 120 clinicians, researchers and MIA staff gathering online to share highlights from our research activities.
Special thanks to the facilitators of each of the 5 research themes - Professor Grant McArthur, Professor Phyllis Butow, Craig Lawn, Assoc Professor Victoria Mar and Assoc Professor David Gyorki
In reviewing the year, Co-Medical Directors Prof Georgina Long AO and Prof Richard Scolyer praised the collaborative efforts of our team by acknowledging the quality and quantity of research that has been undertaken in the last 12 months. Our research has been instrumental in a number of updates to clinical practice guidelines – ultimately affecting change in the management of melanoma patients in Australia and around the world.
With the depth and breadth of research undertaken at MIA, we are harnessing the talents of our people and continuing to work together to reach our goal of zero deaths from melanoma this decade.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Melanoma research saved Bert's life at 101 and now he wants to give back.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.